JP2008545426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545426A5 JP2008545426A5 JP2008514187A JP2008514187A JP2008545426A5 JP 2008545426 A5 JP2008545426 A5 JP 2008545426A5 JP 2008514187 A JP2008514187 A JP 2008514187A JP 2008514187 A JP2008514187 A JP 2008514187A JP 2008545426 A5 JP2008545426 A5 JP 2008545426A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- chain variable
- variable region
- seq
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0511124.0A GB0511124D0 (en) | 2005-06-01 | 2005-06-01 | High affinity melan-a t cell receptors |
| PCT/GB2006/001980 WO2006129085A2 (en) | 2005-06-01 | 2006-05-31 | High affinity melan-a t cell receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545426A JP2008545426A (ja) | 2008-12-18 |
| JP2008545426A5 true JP2008545426A5 (https=) | 2009-07-09 |
Family
ID=34834931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514187A Pending JP2008545426A (ja) | 2005-06-01 | 2006-05-31 | 高親和性メラン−ａｔ細胞レセプター |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8217144B2 (https=) |
| EP (1) | EP1893642A2 (https=) |
| JP (1) | JP2008545426A (https=) |
| CN (1) | CN101189261B (https=) |
| AU (1) | AU2006253941B2 (https=) |
| BR (1) | BRPI0611326A2 (https=) |
| CA (1) | CA2610786A1 (https=) |
| EA (1) | EA012507B1 (https=) |
| GB (1) | GB0511124D0 (https=) |
| MX (1) | MX2007014919A (https=) |
| WO (1) | WO2006129085A2 (https=) |
| ZA (1) | ZA200710009B (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7994298B2 (en) | 2004-09-24 | 2011-08-09 | Trustees Of Dartmouth College | Chimeric NK receptor and methods for treating cancer |
| WO2008039818A2 (en) * | 2006-09-26 | 2008-04-03 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Modified t cell receptors and related materials and methods |
| WO2008042814A2 (en) * | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| EP2087000A2 (en) * | 2006-09-29 | 2009-08-12 | Immunocore Ltd. | T cell therapies |
| GB0816096D0 (en) * | 2008-09-04 | 2008-10-15 | Medigene Ltd | Diabetes t cell receptors |
| GB0911566D0 (en) | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| US12492376B2 (en) | 2009-10-29 | 2025-12-09 | The Trustees Of Dartmouth College | T-cell receptor-deficient T cell compositions |
| WO2011059836A2 (en) | 2009-10-29 | 2011-05-19 | Trustees Of Dartmouth College | T cell receptor-deficient t cell compositions |
| US9273283B2 (en) | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| BR112013022557A2 (pt) * | 2011-03-04 | 2017-08-01 | Shire Human Genetic Therapies | ligantes de peptídeo composições de polipeptídeo e métodos para uso dos mesmos |
| US9833476B2 (en) | 2011-08-31 | 2017-12-05 | The Trustees Of Dartmouth College | NKP30 receptor targeted therapeutics |
| SG10201609210SA (en) * | 2012-05-03 | 2016-12-29 | Hutchinson Fred Cancer Res | Enhanced affinity t cell receptors and methods for making the same |
| ES2719495T5 (en) | 2012-05-07 | 2025-09-10 | Dartmouth College | Anti-b7-h6 antibody, fusion proteins, and methods of using the same |
| EP3718556A3 (en) | 2012-08-31 | 2020-12-30 | University Of Virginia Patent Foundation | Target peptides for immunotherapy and diagnostics |
| EP4088737A3 (en) | 2012-09-05 | 2023-02-08 | University Of Virginia Patent Foundation | Target peptides for colorectal cancer therapy and diagnostics |
| EP3071594A4 (en) * | 2013-11-22 | 2017-05-03 | The Board of Trustees of the University of Illionis | Engineered high-affinity human t cell receptors |
| CA2945816A1 (en) | 2014-04-15 | 2015-10-22 | University Of Virginia Patent Foundation | Isolated t cell receptors and methods of use therefor |
| EP2944652A1 (en) * | 2014-05-13 | 2015-11-18 | Technische Universität München | Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma |
| WO2016014725A1 (en) * | 2014-07-22 | 2016-01-28 | The University Of Notre Dame Du Lac | Molecular constructs and uses thereof |
| GB201417803D0 (en) * | 2014-10-08 | 2014-11-19 | Adaptimmune Ltd | T cell receptors |
| GB201506642D0 (en) | 2015-04-20 | 2015-06-03 | Ucl Business Plc | T cell receptor |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| GB201516277D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR libraries |
| GB201516272D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
| WO2017208018A1 (en) | 2016-06-02 | 2017-12-07 | Immunocore Limited | Dosing regimen for gp100-specific tcr - anti-cd3 scfv fusion protein |
| GB201617714D0 (en) | 2016-10-19 | 2016-11-30 | Ucl Business Plc | T Cell receptor |
| MX2019010972A (es) * | 2017-03-15 | 2019-12-02 | Hutchinson Fred Cancer Res | Receptores de linfocito t (tcr) específicos del antígeno asociado a melanoma 1 (mage-a1) de alta afinidad y usos de estos. |
| US11352389B2 (en) * | 2017-06-30 | 2022-06-07 | Academisch Ziekenhuis Leiden (H.O.D.N. Leids Universitair Medisch Centrum) | Treatment of haematological malignancies |
| US20200308279A1 (en) | 2017-10-06 | 2020-10-01 | Oslo Universitetssykehus Hf | Chimeric antigen receptors |
| CN112646024B (zh) * | 2019-10-10 | 2023-03-24 | 香雪生命科学技术（广东）有限公司 | 一种识别kras突变的t细胞受体及其编码序列 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002321581C1 (en) | 2001-08-31 | 2008-09-18 | Adaptimmune Limited | Soluble T cell receptor |
| US7751825B2 (en) | 2002-06-27 | 2010-07-06 | Qualcomm Incorporated | Controlling geographic location information of devices operating in wireless communication systems |
| AU2003271904B2 (en) | 2002-10-09 | 2009-03-05 | Adaptimmune Limited | Single chain recombinant T cell receptors |
| DE60327795D1 (de) * | 2002-11-09 | 2009-07-09 | Immunocore Ltd | T zell rezeptor "display" |
| JP2006523437A (ja) * | 2002-12-03 | 2006-10-19 | アヴィデックス リミテッド | レセプター複合体 |
| DK1765860T3 (da) * | 2004-05-19 | 2009-03-09 | Immunocore Ltd | Ny-ESO-T.cellereceptor med höj affinitet |
| NZ550815A (en) * | 2004-05-19 | 2009-04-30 | Immunocore Ltd | Method of improving T cell receptors |
-
2005
- 2005-06-01 GB GBGB0511124.0A patent/GB0511124D0/en not_active Ceased
-
2006
- 2006-05-31 JP JP2008514187A patent/JP2008545426A/ja active Pending
- 2006-05-31 AU AU2006253941A patent/AU2006253941B2/en not_active Ceased
- 2006-05-31 CN CN2006800195624A patent/CN101189261B/zh not_active Expired - Fee Related
- 2006-05-31 US US11/915,766 patent/US8217144B2/en not_active Expired - Fee Related
- 2006-05-31 WO PCT/GB2006/001980 patent/WO2006129085A2/en not_active Ceased
- 2006-05-31 EP EP06744042A patent/EP1893642A2/en not_active Withdrawn
- 2006-05-31 BR BRPI0611326-5A patent/BRPI0611326A2/pt not_active IP Right Cessation
- 2006-05-31 MX MX2007014919A patent/MX2007014919A/es not_active Application Discontinuation
- 2006-05-31 EA EA200702677A patent/EA012507B1/ru not_active IP Right Cessation
- 2006-05-31 CA CA002610786A patent/CA2610786A1/en not_active Abandoned
-
2007
- 2007-11-20 ZA ZA200710009A patent/ZA200710009B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545426A5 (https=) | ||
| JP2008535826A5 (https=) | ||
| JP2006502741A5 (https=) | ||
| JP2008509090A5 (https=) | ||
| CA2457652A1 (en) | Soluble t cell receptor | |
| CA2516702A1 (en) | Modified t cell receptor linked by disulphide bond between constant domain cysteine residues | |
| JP2017535527A5 (https=) | ||
| US7691813B2 (en) | Cyclic peptide CXCR4 antagonists | |
| HRP20220865T1 (hr) | T stanični receptori | |
| TW305846B (https=) | ||
| JP2011524420A5 (https=) | ||
| HRP20230542T1 (hr) | T stanični receptori | |
| JP2013518115A5 (https=) | ||
| HRP20231645T1 (hr) | T stanični receptori | |
| WO2017174823A4 (en) | T cell receptors | |
| IL199263A (en) | Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation | |
| JP2012531904A5 (https=) | ||
| AU2368899A (en) | New peptide compounds that are analogues of the glucagon-like peptide-1 (7-37), a process for their preparation and pharmaceutical compositions containing them | |
| EP1251865A1 (en) | Cyclic peptides as potent and selective melanocortin-4 receptor antagonists | |
| NZ601175A (en) | Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same | |
| CZ435783A3 (en) | Synthetic peptides, biologically active fragment and said peptide non-toxic salts | |
| JP2020532496A5 (https=) | ||
| EP3299389A1 (en) | Soluble and stable heterodimeric tcr | |
| CN111183146A (zh) | 高亲和力选择性结合cxcr4的缀合物及其使用方法 | |
| Leprince et al. | Structure–activity relationships of urotensin II and URP |